Recent advances in potential therapeutic targets of ferroptosis‑associated pathways for the treatment of stroke (Review)

Mol Med Rep. 2024 Jul;30(1):128. doi: 10.3892/mmr.2024.13252. Epub 2024 May 24.

Abstract

Stroke is a severe neurological disease that is associated with high rates of morbidity and mortality, and the underlying pathological processes are complex. Ferroptosis fulfills a significant role in the progression and treatment of stroke. It is well established that ferroptosis is a type of programmed cell death that is distinct from other forms or types of cell death. The process of ferroptosis involves multiple signaling pathways and regulatory mechanisms that interact with mechanisms inherent to stroke development. Inducers and inhibitors of ferroptosis have been shown to exert a role in the onset of this cell death process. Furthermore, it has been shown that interfering with ferroptosis affects the occurrence of stroke, indicating that targeting ferroptosis may offer a promising therapeutic approach for treating patients of stroke. Hence, the present review aimed to summarize the latest progress that has been made in terms of using therapeutic interventions for ferroptosis as treatment targets in cases of stroke. It provides an overview of the relevant pathways and molecular mechanisms that have been investigated in recent years, highlighting the roles of inducers and inhibitors of ferroptosis in stroke. Additionally, the intervention potential of various types of Traditional Chinese Medicine is also summarized. In conclusion, the present review provides a comprehensive overview of the potential therapeutic targets afforded by ferroptosis‑associated pathways in stroke, offering new insights into how ferroptosis may be exploited in the treatment of stroke.

Keywords: ferroptosis; stroke; therapeutic target.

Publication types

  • Review

MeSH terms

  • Animals
  • Ferroptosis* / drug effects
  • Humans
  • Medicine, Chinese Traditional / methods
  • Molecular Targeted Therapy
  • Signal Transduction* / drug effects
  • Stroke* / drug therapy
  • Stroke* / metabolism

Grants and funding

This study was supported by The National Natural Science Foundation of China (grant no. 82101410), The Medicine and Health Science and Technology Development Plan Project of Shandong (grant no. 202101040805) and Research and Innovation Plan Project of Weifang Medical University (grant no. 2021BKQ).